Advanced Solid Tumors: Sigvotatug Vedotin

We are studying a new treatment for patients with advanced solid tumors to see how well it works compared to current options. This research aims to improve outcomes for those affected by these cancers.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre Hospitalier Universitaire D'Angers
Service de Pneumologie
Angers, France
Centre Antoine Lacassagne
Département d'Oncologie Médicale
Nice, France
Centre Hospitalier Universitaire De Poitiers
Service d'Oncologie Méicale
Saint-Benoît, France

Sponsor: Seagen Inc.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.